RxDoctor Payments Data

Guy McClary, MD

Family Medicine · Florence, SCNPI 1912168378

Payments from drug & device makers

$12,856in general payments, 2019–2025

Across 854 payments — averaging $15.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$2K
  • Boehringer Ingelheim$1K
  • AbbVie$1K
  • AstraZeneca$949
  • GSK$944
  • Pfizer$813
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$12,842100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk146$1,822
Boehringer Ingelheim78$1,412
AbbVie(2 entities)83$1,172
AstraZeneca60$949
GSK61$944
Pfizer61$813
Amgen(2 entities)29$450
Lilly USA, LLC34$423
Johnson & Johnson28$366
Novartis21$342
Merck25$312
Esperion Therapeutics, Inc.16$268
Amarin Pharma, Inc.16$250
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC15$245
Abbott10$168
Corcept Therapeutics8$167
Takeda Pharmaceuticals U.S.A., Inc.11$158
Sumitomo Pharma America, Inc.6$149
Seqirus USA Inc8$144
Bayer9$143
E.r. Squibb & Sons, L.L.C.9$132
Antares Pharma, Inc.7$130
Exact Sciences7$126
Ironwood Pharmaceuticals, Inc8$118
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$114
Daiichi Sankyo Inc.5$106
Shield Therapeutics Inc6$105
Astellas Pharma US Inc5$93
Biohaven Pharmaceutical Holding Company Ltd.5$87
Axsome Therapeutics, Inc.5$78
Sanofi Pasteur Inc.5$78
Insulet Corporation3$77
Dexcom, Inc.4$73
Teva Pharmaceuticals USA, Inc.5$72
Sanofi-aventis U.S. LLC4$71
Boston Scientific4$67
Sunovion Pharmaceuticals Inc.3$55
Eisai Inc.3$47
Nestle Healthcare Nutrition Inc.3$43
Kaleo, Inc.3$42
Nevro Corp.2$35
Biohaven Pharmaceuticals, Inc.2$33
Mylan Specialty L.p.2$30
Novavax Inc1$25
Scilex Pharmaceuticals Inc.1$25
Clarus Therapeutics Inc.2$24
Phathom Pharmaceuticals, Inc.2$23
Hologic Sales And Service, LLC1$21
Dynavax Technologies Corporation1$20
Impel Pharmaceuticals Inc.1$18
Corium, LLC1$18
Xeris Pharmaceuticals, Inc.1$18
Genentech USA, Inc.1$15
Edwards Lifesciences1$15
Arbor Pharmaceuticals, Inc.1$15
Upsher-smith Laboratories LLC1$15
Halozyme Inc1$14
Otsuka America Pharmaceutical, Inc.1$13
Cvrx, Inc.1$13
Hikma Pharmaceuticals USA1$13

How this compares

$12,856 in reported general payments places this provider in the 95th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$279,689
Medicare patients
566
Services billed
4,377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide147$200,782
EliquisApixaban134$155,712
FarxigaDapagliflozin Propanediol128$122,571
JardianceEmpagliflozin100$98,465
TrulicityDulaglutide65$81,001
XareltoRivaroxaban94$78,638
JanuviaSitagliptin Phosphate41$47,854
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$28,581
EntrestoSacubitril/Valsartan13$22,126
MounjaroTirzepatide20$20,474
LipitorAtorvastatin Calcium11$16,846
MyrbetriqMirabegron24$14,853
NorvascAmlodipine Besylate18$14,547
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog24$13,397
Breo ElliptaFluticasone/Vilanterol22$12,223

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,822$200,782147 claims
PfizerEliquis, Lipitor$813$172,558145 claims
AstraZenecaFarxiga$949$122,571128 claims
Boehringer IngelheimJardiance, Synjardy$1,412$105,067113 claims
Lilly USA, LLCTrulicity, Mounjaro$423$101,47585 claims
Johnson & JohnsonXarelto$366$78,63894 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$944$48,24364 claims
MerckJanuvia$312$47,85441 claims
NovartisEntresto$342$22,12613 claims
AbbVieSynthroid, Linzess$1,172$18,884138 claims
Astellas Pharma US IncMyrbetriq$93$14,85324 claims
Esperion Therapeutics, Inc.Nexlizet$268$4,13211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Florence

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →